Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
16.06
-0.52 (-3.14%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Immunic Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Immunic stock has a consensus rating of "Strong Buy" and an average price target of $41.9. The average 1-year stock price forecast is 160.90% higher than the current stock price, while the lowest is $19 (+18.31%) and the highest is $85 (+429.27%).
Price Target: $41.9 (+160.90%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 10 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $22 | Buy | Reiterates | $22 | +36.99% | Aug 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Reiterates $25 | Buy | Reiterates | $25 | +55.67% | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $56 | Buy | Maintains | $56 | +248.69% | Aug 12, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $70 | Buy | Reiterates | $70 | +335.87% | Aug 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.79
from -6.20
EPS Next Year
-2.53
from -3.79
EPS and Forward PE are based on non-GAAP adjusted numbers.